Results 11 to 20 of about 56,455 (308)
Clinical Characteristics and Management of Cerebral Venous Sinus Thrombosis in Patients With Antiphospholipid Syndrome: A Single-Center Retrospective Study [PDF]
Clinical and applied thrombosis/hemostasis, 2021 Antiphospholipid syndrome (APS) with cerebral venous sinus thrombosis (CVST) is a relatively rare phenomenon, and this observational study aimed to investigate the clinical characteristics of APS patients complicated with CVST.
Huixin Shen, Xiaoqin Huang, Chunqiu Fan
openalex +2 more sources
Cerebral Venous Sinus Thrombosis Following Neuraxial Labor Analgesia: A Case Report. [PDF]
Clin Case RepABSTRACT We describe a case of cerebral venous sinus thrombosis (CVST) in a 25‐year‐old primigravid woman after receiving epidural analgesia during labor. Her initial presentation mimicked postdural puncture headache (PDPH), but her condition evolved to include progressive neurological symptoms.
Tong Q, Zhong M, Han X.
europepmc +2 more sources
Journal of the American Medical Association (JAMA), 2021 Importance Cerebral venous sinus thrombosis (CVST) with thrombocytopenia, a rare and serious condition, has been described in Europe following receipt of the ChAdOx1 nCoV-19 vaccine (Oxford/AstraZeneca), which uses a chimpanzee adenoviral vector.
I. See +23 more
semanticscholar +1 more source
JAMA Neurology, 2021 Importance Thrombosis with thrombocytopenia syndrome (TTS) has been reported after vaccination with the SARS-CoV-2 vaccines ChAdOx1 nCov-19 (Oxford-AstraZeneca) and Ad26.COV2.S (Janssen/Johnson & Johnson).
M. Sánchez van Kammen +122 more
semanticscholar +1 more source
Neutrophil extracellular traps promote thrombogenicity in cerebral venous sinus thrombosis
Cell & Bioscience, 2022 Neutrophil extracellular traps (NETs) contribute to the creation of a coagulation state in various diseases. Currently, it is not clear whether NETs are present in the thrombi and plasma of patients with cerebral venous sinus thrombosis (CVST).
Jiaqi Jin +13 more
semanticscholar +1 more source
Cerebral Venous Sinus Thrombosis Following COVID-19 Vaccination: A Systematic Review
Journal of Primary Care & Community Health, 2022 Introduction: COVID-19 vaccines became available after being carefully monitored in clinical trials with safety and efficacy on the human body. However, a few recipients developed unusual side effects, including cerebral venous sinus thrombosis (CVST ...
Vikash Jaiswal +13 more
semanticscholar +1 more source
Cerebral Venous Sinus Thrombosis following COVID-19 Vaccination: Analysis of 552 Worldwide Cases
Vaccines, 2022 To date, billions of vaccine doses have been administered to restrain the current COVID-19 pandemic worldwide. Rare side effects, including intravascular blood clots, were reported in the general population after vaccination. Among these, cerebral venous
C. de Gregorio +10 more
semanticscholar +1 more source
BMJ Case Reports, 2021 A 27-year-old fit and well man presented with intermittent headaches associated with eye floaters and vomiting. His symptoms started 48 hours after having the first dose of ChADOx1 nCOV-19 vaccine (Vaxzevria, previously AstraZeneca COVID-19 vaccine ...
P. Suresh, W. Petchey
semanticscholar +1 more source
Radiology Case Reports, 2020 Cerebral venous sinus thrombosis is an uncommon disorder that requires prompt diagnosis and treatment to prevent serious complications. Due to the broad spectrum of clinical presentations, patients typically undergo noncontrast CT as the first imaging ...
Emily Neal, John Sturgeon, MD
doaj +1 more source
Clinical and radiological features of cerebral venous thrombosis by the example of clinical cases
Клинический разбор в общей медицине, 2023 Venous blood accounts for more than 80% of cerebral blood flow. At the same time, the incidence of cerebral venous thrombosis in patients with ischaemic stroke is only 3%.
Oleg V. Zolotarev +3 more
doaj +1 more source